US3709201004
US3709201004
Generate Biomedicines, Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 31.893.000 | 20.459.000 | 55.9% |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| 266.958.000 | 217.398.000 | 22.8% | |
| Operating Income | -235.065.000 | -196.939.000 | 19.4% |
| Pretax Income | -222.802.000 | -181.172.000 | 23.0% |
| Net Income Common Stockholders | -249.523.000 | -213.777.000 | 16.7% |
| -- | -- | -- | |
| -- | -- | -- |